Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 214,010 | 213,752 | 246,994 | 148,813 | 245,197 |
| Marketable Securities | 79,526 | 36,194 | 39,206 | 144,782 | 237,299 |
| Receivables | 115,307 | 101,099 | 87,632 | 66,196 | 52,672 |
| Inventories | 228,819 | 118,782 | 59,696 | 23,816 | 26,818 |
| TOTAL | $676,173 | $504,736 | $483,061 | $423,816 | $596,834 |
| Non-Current Assets | |||||
| PPE Net | 27,108 | 29,383 | 31,667 | 30,778 | 42,496 |
| Intangibles | 211,712 | 214,995 | 218,287 | 220,797 | 197,797 |
| Other Non-Current Assets | 34,877 | 35,919 | 44,865 | 48,776 | 68,013 |
| TOTAL | $273,697 | $280,297 | $294,819 | $300,351 | $308,306 |
| Total Assets | $949,870 | $785,033 | $777,880 | $724,167 | $905,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28,630 | 12,947 | 15,120 | 36,830 | 40,413 |
| Accrued Expenses | 200,457 | 127,300 | 144,245 | 93,636 | 98,153 |
| TOTAL | $237,828 | $148,702 | $167,689 | $139,018 | $145,975 |
| Non-Current Liabilities | |||||
| Long Term Debt | 392,660 | 390,111 | 387,858 | 391,990 | 389,357 |
| Other Non-Current Liabilities | 45,141 | 52,175 | 62,159 | 70,112 | 51,603 |
| TOTAL | $437,801 | $442,286 | $450,017 | $462,102 | $451,796 |
| Total Liabilities | $675,629 | $590,988 | $617,706 | $601,120 | $597,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 314,001 | 300,116 | 295,383 | 282,715 | 280,029 |
| Common Shares | 3,037 | 2,944 | 2,918 | 2,815 | 2,808 |
| Retained earnings | -2,767,290 | -2,740,180 | -2,684,074 | -2,532,490 | -2,295,922 |
| Other shareholders' equity | 24,038 | 5,166 | 5,312 | -12,022 | 5,064 |
| TOTAL | $274,241 | $194,045 | $160,174 | $123,047 | $307,369 |
| Total Liabilities And Equity | $949,870 | $785,033 | $777,880 | $724,167 | $905,140 |